Early Access — free while we kick the tires
EdgarHawk

Louie Ngar Yee

Director

Director
1 filing analyzed · 1 company · Latest 2025-12-23

Companies

Company Buys Sells Direction
MAIA Biotechnology, Inc. MAIA 1 0 Net buying

Activity

December 2025
high
Buy
81,699 shares
$100,000
Significance 7/10

Director Louie Ngar Yee bought 81,699 shares of MAIA at $1.22; insider's prior 3 MAIA buys all posted 90-day gains; company is unprofitable ($-8.9M net income); cluster buy pattern.

Louie Ngar Yee purchased 81,699 shares at $1.22 on 2025-12-22, increasing his holdings to 1.25M shares and joining 2 other insiders in buying MAIA within the past 14 days. His prior trade timing at MAIA is notably consistent: all 3 of his earlier purchases at this ticker (2024-04-25, 2024-03-14, 2023-04-27) delivered positive 90-day returns (+84.2%, +88.5%, and +2.2% respectively), indicating a pattern of well-timed entry points. The current environment presents a sharp contrast to his historical execution: MAIA trades 45.2% below its 52-week high and the company reported full-year net income of $-8.9M, highlighting fundamental weakness that stands apart from the price-action timing signal. The synchronized cluster buying by multiple insiders warrants monitoring alongside the insider's demonstrated historical pattern at this specific ticker, though the company's unprofitable status creates structural headwinds independent of insider positioning.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access